Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
5.17
+0.01 (0.29%)
At close: May 12, 2025, 4:00 PM
5.16
0.00 (-0.10%)
After-hours: May 12, 2025, 4:00 PM EDT

Third Harmonic Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
23.3822.3719.9913.33.261.17
Research & Development
40.9236.523.9624.4115.759.95
Operating Expenses
64.358.8743.9537.711911.12
Operating Income
-64.3-58.87-43.95-37.71-19-11.12
Interest Expense
----0--
Interest & Investment Income
12.8613.4113.112.560.01-
Other Non Operating Income (Expenses)
-0.01-0.010.02---
EBT Excluding Unusual Items
-51.45-45.47-30.82-35.16-19-11.12
Other Unusual Items
-----10.61-1.69
Pretax Income
-53.45-45.47-30.82-35.16-29.61-12.81
Net Income
-53.45-45.47-30.82-35.16-29.61-12.81
Net Income to Common
-53.45-45.47-30.82-35.16-29.61-12.81
Shares Outstanding (Basic)
4342401444
Shares Outstanding (Diluted)
4342401444
Shares Change (YoY)
8.23%5.26%176.22%254.97%10.23%-
EPS (Basic)
-1.25-1.09-0.78-2.45-7.32-3.49
EPS (Diluted)
-1.25-1.09-0.78-2.45-7.32-3.49
Free Cash Flow
-41.7-34.51-20.59-34.95-15.75-9.19
Free Cash Flow Per Share
-0.97-0.83-0.52-2.44-3.89-2.50
EBITDA
-64.25-58.82-43.92-37.71--
D&A For EBITDA
0.050.050.040--
EBIT
-64.3-58.87-43.95-37.71-19-11.12
Updated Mar 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q